These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23134100)

  • 1. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
    Smithburger PL; Kane-Gill SL; Seybert AL
    Int J Pharm Pract; 2012 Dec; 20(6):402-8. PubMed ID: 23134100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US.
    Smithburger PL; Kane-Gill SL; Seybert AL
    Drug Saf; 2010 Oct; 33(10):879-88. PubMed ID: 20812772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings.
    Smithburger PL; Kane-Gill SL; Benedict NJ; Falcione BA; Seybert AL
    Ann Pharmacother; 2010 Nov; 44(11):1718-24. PubMed ID: 20959499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
    Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
    Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug interactions and adverse events induced by drugs used in an intensive care unit].
    Plaza J; Alamo M; Torres P; Fuentes A; López F
    Rev Med Chil; 2010 Apr; 138(4):452-60. PubMed ID: 20668793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of drug interactions in hospitals--computerized screening vs. bedside recording.
    Blix HS; Viktil KK; Moger TA; Reikvam A
    J Clin Pharm Ther; 2008 Apr; 33(2):131-9. PubMed ID: 18315778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication errors during medical emergencies in a large, tertiary care, academic medical center.
    Gokhman R; Seybert AL; Phrampus P; Darby J; Kane-Gill SL
    Resuscitation; 2012 Apr; 83(4):482-7. PubMed ID: 22001000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
    Farzanegan B; Alehashem M; Bastani M; Baniasadi S
    J Clin Pharmacol; 2015 Feb; 55(2):132-6. PubMed ID: 25369984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically important drug-drug interactions in primary care.
    Dhabali AA; Awang R; Zyoud SH
    J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
    Gülçebi İdriz Oğlu M; Küçükibrahimoğlu E; Karaalp A; Sarikaya Ö; Demirkapu M; Onat F; Gören MZ
    Turk J Med Sci; 2016 Apr; 46(3):812-9. PubMed ID: 27513261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.